Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study

Author:

Huang Hai1,Zhang Yanlin1,Li Sheng1,Wang Jun1,Chen Jun2,Pan Zhiyun1,Gan Hui13

Affiliation:

1. Department of Tuberculosis Specialty, Wuhan Pulmonary Hospital, Wuhan, China.

2. Department of Mycobacteriology Laboratory, Wuhan Pulmonary Hospital, Wuhan, China.

3. Department of Allergy, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.

Publisher

Mary Ann Liebert Inc

Subject

Microbiology (medical),Pharmacology,Immunology,Microbiology

Reference19 articles.

1. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data

2. Drug-resistant tuberculosis control in China: progress and challenges

3. The Prevalence of Drug-Resistant Tuberculosis in Mainland China: An Updated Systematic Review and Meta-Analysis

4. Picking Up the Pace — Scale-Up of MDR Tuberculosis Treatment Programs

5. World Health Organization. 2011. Policy Statement: Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System. World Health Organization, Geneva, Switzerland.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3